Endocrine Disruptors, The European Green Deal And The Politicization Of EU Chemical Programs
Executive Summary
John Chave, director-general at Cosmetics Europe, says the European Commission’s plan for targeted assessment of 28 potential endocrine-disruptors in cosmetics – despite its conclusion in late 2018 that the current cosmetics regulatory framework adequately addresses endocrine-disruptor concerns – is symptomatic of a broad trend taking hold in Europe.
You may also be interested in...
US And Trading Neighbors Advocate Risk-Based, Science-Backed Cosmetics Regs
As European industry’s concerns grow about “politicization” of regulatory programs, the United States-Mexico-Canada Agreement’s cosmetics annex directs regulatory authorities pursuing new rules to give due consideration to scientific and technical guidance documents developed through international collaboration.
EU’s Cosmetic Microplastic Restriction Expected To Be ‘Very Wide-Ranging’ At Best
Cosmetics Europe’s Director-General John Chave discusses next steps in the European Union’s proposed drive to ban manufactured microplastic in all cosmetic products. Industry continues to fight for something more proportionate, but it’s up against powerful forces in today’s European theater.
PCPC: State Legislation, ‘Fake Science,' FDA’s Sunscreen Monograph Among Top 2019 Challenges
The Personal Care Products Council’s top execs identified key legislative, regulatory and public affairs challenges facing industry in 2019 during a Feb. 26 panel discussion at the group’s annual meeting in Palm Beach, Fla.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests:
